The 2025 edition of the Chinese Pharmacopoeia comprises 6,385 monographs in total: 159 newly added, 1,101 revised, and 32 deleted.
Part I (Traditional Chinese Medicines): 3,069 monographs, including 28 newly added, 420 revised, and 19 deleted.
Part II (Chemical Medicines): 2,776 monographs,including 66 newly added, 483 revised. Two monographs, namely Purified Water and Water for Injection,are transferred from Part II to Part IV.
Part III (Biological Products): 153 monographs, including 13 newly added, 62 revised, and 13 deleted.
Part IV (General Chapters and Pharmaceutical Excipients): 387 mono~graphs, including 52 newly added and 136 revised.
This edition features 410 general technical requirements, with 69 newly added and 133 revised.Part III (Biological Products): 13 newly added general chapters and 31 revised general chapters. Part IV(General Chapters and Pharmaceutical Excipients): 56 newly added general chapters and 102 revised generalchapters.
There are 72 guidelines in this edition: 33 newly added, 17 revised, and 3 deleted. Part III (Biologi-cal Products): 5 newly added guidelines.Part IV(General Chapters and Pharmaceutical Excipients): 28newly added, 17 revised, and 3 deleted guidelines.















